Former Chief Medical Officer · Protara Therapeutics, Inc. (TARA)

Jathin Bandari

FY2024 is the first fiscal year CompBrief holds for Jathin Bandari as a named executive officer of Protara Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,081,276

Salary $135,378Stock awards $43,930Bonus $150,000

3rd of 4 named executive officers at Protara Therapeutics by FY2024 total.

4 named officers on file for Protara Therapeutics, FY2024

Jathin Bandari’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Protara Therapeutics’s whole pay program stands against its peers

  • Protara Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TARA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Jathin Bandari’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jathin Bandari compensation by year

Protara Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Protara Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$135,378
Bonus$150,000
Stock awards$43,930
Option awards$208,226
Non-equity incentive$0
Pension and deferred compensation$0
All other$543,742
Total$1,081,276

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0001213900-25-035568, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Protara Therapeutics, Inc. filed document, accession 0001213900-25-035568. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

Protara Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jesse SheffermanPresident, Chief Executive Officer and Director$1,791,843
Jacqueline ZummoChief Scientific Operations Officer$1,214,189
Jathin Bandari · this pageFormer Chief Medical Officer$1,081,276
Patrick FabbioChief Financial Officer$1,023,536

The full Protara Therapeutics compensation record

free company brief

This page is one person within Protara Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jathin Bandari's compensation dossier · One-time report. No refunds.